Search clinical trials for: Abiraterone
Total 334 results
-
GlaxoSmithKlineWithdrawn
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
University Health Network, TorontoCompleted
-
Hongqian GuoFirst Affiliated Hospital of Zhejiang University; Nanjing First Hospital, Nanjing... and other collaboratorsRecruitingNeoadjuvant TherapyChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
CellCentric Ltd.RecruitingAdvanced Solid Tumors | Metastatic Breast Cancer | Non-small Cell Lung Cancer | Metastatic Castration-Resistant Prostate CancerUnited Kingdom, United States, Netherlands, France, Spain, Sweden
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
Janssen Research & Development, LLCActive, not recruitingCastration-Resistant Prostatic CancerUnited States, China, Italy, Korea, Republic of, Taiwan, Australia, Sweden, Belgium, Canada, France, Hungary, Israel, Malaysia, Russian Federation, Portugal, Germany, Bulgaria, Spain, Netherlands, Turkey, United Kingdom, Ukraine, Po... and more
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.Active, not recruiting
-
Carolina Research Professionals, LLCBayerCompleted
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
GlaxoSmithKlineTerminatedSolid TumoursUnited States, Spain, Australia, United Kingdom
-
Janssen Research & Development, LLCApproved for marketingMetastatic Castration-resistant Prostate CancerBrazil, Austria, Estonia, Israel, Mexico
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingProstate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); AbbVie; Rutgers Cancer Institute of New JerseyTerminated
-
zr Pharma & GmbHCompletedMetastatic Castration Resistant Prostate CancerUnited States
-
Rohan GarjeJanssen Scientific Affairs, LLCNot yet recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Fudan UniversityRecruitingProstate Cancer | Castration-resistant Prostate Cancer | Metastatic DiseaseChina
-
Janssen Research & Development, LLCActive, not recruitingProstatic Neoplasms, Castration-ResistantBelgium, United States, United Kingdom, Canada, Israel, Spain, Italy
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited States
-
American University of Beirut Medical CenterNot yet recruitingCOPD Exacerbation | Chronic Obstructive Pulmonary Disease Exacerbation
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
Janssen Research & Development, LLCRecruitingMetastatic Castration-resistant Prostate NeoplasmsUnited States, Australia
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; Weill Medical College of Cornell University; Janssen...Active, not recruiting
-
GlaxoSmithKlineCompleted
-
Arno TherapeuticsUnknownRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate CancerUnited Kingdom
-
University of CalgaryTerminated
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Instituto do Cancer do Estado de São PauloJanssen, LPCompleted
-
University of HawaiiTerminated
-
Masonic Cancer Center, University of MinnesotaWithdrawn
-
University of Roma La SapienzaCompletedDiabetes Mellitus, Type 2 | Endothelial DysfunctionItaly
-
Rambam Health Care CampusCanadian Institutes of Health Research (CIHR); Hadassah Medical Organization; McGill University Health Centre/Research Institute of the McGill University Health Centre and other collaboratorsRecruitingBacteremia | Enterobacteriaceae Infections | Beta Lactam Resistant Bacterial InfectionIsrael, Canada
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...The First Affiliated Hospital of Soochow University; The Affiliated Hospital... and other collaboratorsActive, not recruitingProstatectomy | Oligometastatic Prostate Cancer | AbirateroneChina
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
Sun Pharmaceutical Industries LimitedCompleted
-
Curium US LLCActive, not recruitingMetastasis From Malignant Tumor of ProstateUnited States, France, Spain, Italy
-
ExelixisTerminatedTriple Negative Breast Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States
-
Syneos HealthAntares Pharma Inc.WithdrawnMetastatic Castration-resistant Prostate Cancer
-
Radboud University Medical CenterJanssen-Cilag Ltd.CompletedMetastatic Castration Resistant Prostate CancerNetherlands
-
Johnson & Johnson Private LimitedWithdrawn
-
Kristoffer Staal RohrbergJanssen-Cilag Ltd.Terminated
-
Centre Antoine LacassagneCompletedPharmacogenetic StudyFrance
-
Zentiva, k.s.CompletedPharmacokineticsUnited Kingdom
-
University of British ColumbiaUniversity Health Network, Toronto; Janssen Inc.RecruitingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer (GUNS)Prostate CancerCanada, United States
-
National Cancer Institute (NCI)Active, not recruitingCastrate Sensitive Prostate CancerUnited States
-
Epizyme, Inc.Active, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, Belgium